We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$6.19B
Cap. Flow %
2.39%
Top 10 Hldgs %
14.4%
Holding
8,581
New
810
Increased
3,917
Reduced
2,792
Closed
626

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$1.59B
2
AGN
Allergan plc
AGN
+$763M
3
BA icon
Boeing
BA
+$639M
4
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$542M
5
AAPL icon
Apple
AAPL
+$402M

Top Sells

Rank Stock Value
1
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$377M
2
ECL icon
Ecolab
ECL
+$332M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$315M
4
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$306M
5
CELG
Celgene Corp
CELG
+$250M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.11%
2 Technology 9.86%
3 Financials 7.52%
4 Healthcare 6.59%
5 Consumer Discretionary 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INMB icon
7576
INmune Bio
INMB
$63M
$2K ﹤0.01%
287
-922
-76% -$9.33K
KZIA
7577
Kazia Therapeutics
KZIA
$164M
$2K ﹤0.01%
15
-16
-52% -$2.46K
LFT
7578
Lument Finance Trust
LFT
$34.2M
$2K ﹤0.01%
63
– –
LTBR icon
7579
Lightbridge
LTBR
$234M
$2K ﹤0.01%
293
– –
MLSS icon
7580
Milestone Scientific
MLSS
$38.3M
$2K ﹤0.01%
4,499
-3,793
-46% -$1.38K
BINI
7581
DELISTED
Bollinger Innovations
BINI
– –
0
– –
NNVC icon
7582
NanoViricides
NNVC
$37M
$2K ﹤0.01%
410
+347
+551% +$1.78K
OCUL icon
7583
Ocular Therapeutix
OCUL
$2.22B
$2K ﹤0.01%
500
– –
PAVM icon
7584
PAVmed
PAVM
$38.4M
$2K ﹤0.01%
+5
New +$2.64K
QRHC icon
7585
Quest Resource Holding
QRHC
$29.3M
$2K ﹤0.01%
494
+244
+98% +$559
QUAD icon
7586
Quad
QUAD
$484M
$2K ﹤0.01%
240
-270
-53% -$2.83K
QWLD
7587
State Street SPDR MSCI World StrategicFactors ETF
QWLD
$176M
$2K ﹤0.01%
+30
New +$2.35K
HIND
7588
Vyome Holdings
HIND
$13.8M
– –
0
– –
RVP icon
7589
Retractable Technologies
RVP
$21M
$2K ﹤0.01%
2,565
+2,563
+128,150% +$1.77K
SFYF icon
7590
SoFi Social 50 ETF
SFYF
$42.8M
$2K ﹤0.01%
+100
New +$1.96K
SYPR icon
7591
Sypris Solutions
SYPR
$41.2M
$2K ﹤0.01%
1,950
-7,190
-79% -$6.69K
TENX icon
7592
Tenax Therapeutics
TENX
$71.1M
$2K ﹤0.01%
1
-3
-75% -$7.26K
TRMD icon
7593
TORM
TRMD
$3.96B
$2K ﹤0.01%
258
+239
+1,258% +$2.12K
TTNP
7594
DELISTED
Titan Pharmaceuticals
TTNP
$2K ﹤0.01%
3
-10
-77% -$9.14K
UONE icon
7595
Urban One Class A
UONE
$19.5M
$2K ﹤0.01%
104
-50
-32% -$1.07K
USL icon
7596
United States 12 Month Oil Fund,
USL
$48.3M
$2K ﹤0.01%
90
– –
VICR icon
7597
Vicor
VICR
$9.88B
$2K ﹤0.01%
82
-7,242
-99% -$233K
WRN
7598
Western Copper and Gold
WRN
$538M
$2K ﹤0.01%
3,515
+3,365
+2,243% +$1.86K
XPRO icon
7599
Expro Ltd
XPRO
$1.83B
$2K ﹤0.01%
54
-540
-91% -$19.5K
XYF
7600
X Financial
XYF
$185M
$2K ﹤0.01%
+171
New +$2.45K
302 303
304
305 306

Similar funds

Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q2 2019 filing shows 810 new, 3,917 increased, 2,792 reduced and 626 closed positions. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M. The largest sale was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 810 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.